Biofil Chemicals & Pharmaceuticals Limited — Others, 17-02-2025: Shareholders meeting

Biofil Chemicals and Pharmaceuticals Limited plans to conduct a postal ballot to seek shareholder approval for key decisions. Proposed items include confirming the appointment of Mr. Meet Shah as a Promoter Non-Executive Non-Independent Director and approving related-party transactions involving the sale of assets to Cyano Pharma Private Limited and Formo Plast Private Limited, valued at ₹2.15 crore and ₹2 crore, respectively. The remote e-voting will occur from February 20 to March 21, 2025. This initiative could reinforce governance structures while offering liquidity through asset sales, potentially fostering a positive outlook among investors.